Shots: The approval is based on P-III CASSIOPEIA studyassessingDarzalex + bortezomib, thalidomide and dexamethasone (VTd) vs VTd in 1085 newly diagnosed patients with previously untreated, symptomatic MM, who were eligible […]readmore
Tags : Newly Diagnosed Multiple Myeloma
Regulatory
Janssen’s Darzalex (daratumumab) Combination Regimen Receives CHMP’s Positive Opinion for
Shots: The CHMP positive opinion is based on P-III CASSIOPEIA (MMY3006) study assessing the combination of Darzalex + bortezomib, thalidomide and dexamethasone vs bortezomib, thalidomide and dexamethasone alone in 1,085 […]readmore
Regulatory
Janssen’s Darzalex (daratumumab) Combination Regimen Receives EC’s Approval for Transplant
Shots: The EC’s approval is based on P-III MAIA study assessing Darzalex + lenalidomide and dexamethasone (DRd) vs Rd in 737 newly diagnosed patients aged 45-90yrs. with multiple myeloma ineligible […]readmore